JPMorgan on Boston Scientific (BSX): 'We’d be buyers of BSX on any material weakness'
Tweet Send to a Friend
JPMorgan analyst Robbie Marcus reiterated an Overweight rating and $135.00 price target on Boston Scientific (NYSE: BSX)The analyst comments "On ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
